IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model

Published:2022-12 Issue: Volume:174 Page:14-26
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Feng Yuqian,Yan Sheng,Lam Sze Kwan,Ko Frankie Chi Fat,Chen Caoyang,Khan Mahjabin,Ho James Chung-Man

Funder

Research Grants Council, University Grants Committee

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference52 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front. Pharmacol.,2017

3. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer;Forde;N. Engl. J. Med.,2018

4. A brief history of IL-9;Goswami;J. Immunol.,2011

5. IL-9-producing T cells: potential players in allergy and cancer;Angkasekwinai;Nat. Rev. Immunol.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy;Frontiers in Immunology;2024-08-30

2. Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy;Cells;2024-06-28

3. Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer;Nature Communications;2024-05-24

4. Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc;Nature Metabolism;2024-05-03

5. Immune function of colon cancer associated miRNA and target genes;Frontiers in Immunology;2023-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3